Good MorningVolatility returned to the stock market on Friday. The week ended on a down note with the major indices all down more than 2.0% at the lows of the day. The move can be chalked up to growing anxiety that was fueled by Friday’s economic data. While the data is generally positive with income, spending, and manufacturing activity all on the rise there is a dark cloud to be wary of. A surprise jump in core inflation has investors spooked the FOMC’s easy-money zero-interest-rate policy could end sooner than expected.
Next week could be a tough one for investors. The price action in the S&P 500 suggests the index will post lower prices sooner than higher and that is backed up by the VIX. The fear-index surged to multi-month highs early in the week and maybe in a reversal. A rise in the VIX usually coincides with a drop in the S&P 500 and it could be a big one.
Featured: He Called NVIDIA at $1.10 – Now He Says, “SELL” (Ad) 
|
Auto/Tires/Trucks | | Regulation Is Lifting The EV Market, Nikola Too
The entire electric vehicle industry is getting a lift from the Biden administration. The president has already issued executive orders that strengthen the U.S. fight against climate change and the EV industry at large. Among them are a number of orde... Read the Full Story |
|
From Our Partners | | When the SpaceX IPO launches, most retail investors will be locked out. The banks, funds, and insiders get in early - while everyone else waits on the sidelines.
But one small infrastructure supplier - a critical piece Musk can't scale the Colossus network without - is still trading well under institutional radar. A new briefing reveals the name and ticker at no cost. | | Get the SpaceX infrastructure stock name and ticker here |
|
Markets | | Special purpose acquisition company (SPAC) Stable Road Acquisition Corp. (NYSE: SRAC) stock has been on a tear in 2021, up 38% year-to-date (YTD) as of Jan. 23, 2021. Shares took a hit when the much anticipated Virgin Galactic (NYSE: SPCE) second flight test mission failed on Dec. 11, 2020. Space th... Read the Full Story |
|
Technology | |
It’s fair to say that this earnings season has largely been overshadowed by other big headlines about the stock market. While those stories might be fascinating, investors should not get distracted from several companies that have reported some very impressive numbers. Many of these business... Read the Full Story |
|
From Our Partners | | Marc Chaikin, the Wall Street veteran who spotted Nvidia before a 45,000% run, says there's a simple trade available in your brokerage account today that offers backdoor pre-IPO exposure to SpaceX.
With the IPO date approaching, Chaikin believes this position could benefit from as high as a $122 billion windfall on IPO day - and he warns against buying in on day one due to potential price instability. | | See exactly how to make this trade before SpaceX goes public |
|
Industrials | |
There's no doubt that the coronavirus hit a lot of companies hard, and Caterpillar (NYSE:CAT) wasn't much of an exception. It actually saw some benefits, but took some hits as well. Caterpillar's latest earnings report demonstrates you can't keep a good heavy equipment manufacturer down. It turned... Read the Full Story |
|
Business Services | |
Even the most casual observer likely already knew that Visa (NYSE:V) was a pretty safe stock to pick up. The last year for Visa has proved that point with almost staggering abundance. The latest earnings report issued from the company only adds icing to an already rich fiduciary cake and shows us ... Read the Full Story |
|
From Our Partners | | The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings.
Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds.
If any of these are in your portfolio, now is the time to review your positions. | | See the 5 stocks to avoid |
|
Medical | | Abbott Laboratories Bull Run Is Far From Over
Abbott Laboratories (NYSE: ABT) has long been a favorite of ours here at MarketBeat. The company is not only well-positioned as a biotech/pharma whose business is anchored in consumer and staple-type products but is also one of the best-managed company&... Read the Full Story |
|
Technology | |
For better or worse, we've learned that there is power in number these days. Whether it be the storming of the U.S. Capitol or its stock market equivalent, a coordinated trading attack on hedge funds, gathering enough people for a cause can uproot the fundamental principles of society—and st... Read the Full Story |
|
Retail/Wholesale | | Tractor Supply Will Sustain Growth Into 2021
Tractor Supply Company (NASDAQ:TSCO) was one of the hottest names among the stay-at-home/play-at-home winnerslast year. The company is a modern-day general store for outdoor enthusiasts of all variety from hobby urban gardeners all the way through full-b... Read the Full Story |
|
Transportation | | On Thursday, shares of American Airlines (NASDAQ: AAL) came within a couple of cents of their post COVID high, as they jumped as much as 30%. While they gave back most of the gains into the close, they still finished up a respectable 9% with their second highest daily volume of the year.
So what&rs... Read the Full Story |
|
Finance | |
Given the recent spikes in volatility and declining market breadth, now is a great time to start thinking about which stocks you might be compelled to buy if the market enters a corrective phase. That way, investors can be prepared to take advantage of any significant declines in the share prices ... Read the Full Story |
|
The Early Bird Stock Of The Day Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. | | View Today's Stock Pick |
|
